Fluoxetina [Inn-Spanish] en es it fr

Fluoxetina [Inn-Spanish] Brand names, Fluoxetina [Inn-Spanish] Analogs

Fluoxetina [Inn-Spanish] Brand Names Mixture

  • No information avaliable

Fluoxetina [Inn-Spanish] Chemical_Formula


Fluoxetina [Inn-Spanish] RX_link


Fluoxetina [Inn-Spanish] fda sheet

Fluoxetina_[Inn-Spanish] FDA

Fluoxetina [Inn-Spanish] msds (material safety sheet)

Fluoxetina_[Inn-Spanish] MSDS

Fluoxetina [Inn-Spanish] Synthesis Reference

B. B. Mally; K. K. Schmiegel; U.S. Pat. 4,314,081 (1982)

Fluoxetina [Inn-Spanish] Molecular Weight

309.326 g/mol

Fluoxetina [Inn-Spanish] Melting Point


Fluoxetina [Inn-Spanish] H2O Solubility

50 mg/mL at 25°C

Fluoxetina [Inn-Spanish] State


Fluoxetina [Inn-Spanish] LogP


Fluoxetina [Inn-Spanish] Dosage Forms

Capsule; Liquid; Solution

Fluoxetina [Inn-Spanish] Indication

For the treatment of depression, obsessive compulsive disorder, and bulimia nervosa.

Fluoxetina [Inn-Spanish] Pharmacology

Fluoxetine, an antidepressant agent belonging to the selective serotonin reuptake inhibitors (SSRIs), is used to treat depression, bulimia nervosa, premenstrual dysphoric disorder, panic disorder and post-traumatic stress. According to the amines hypothesis, a functional decrease in the activity of amines, such as serotonin and norepinephrine, would result in depression; a functional increase of the activity of these amines would result in mood elevation. Fluoxetine's effects are thought to be associated with the inhibition of 5HT receptor, which leads to an increase of serotonin level.

Fluoxetina [Inn-Spanish] Absorption


Fluoxetina [Inn-Spanish] side effects and Toxicity

Symptoms of overdose include agitation, restlessness, hypomania, and other signs of CNS excitation. LD50=284mg/kg (orally in mice).

Fluoxetina [Inn-Spanish] Patient Information

Fluoxetina [Inn-Spanish] Organisms Affected

Humans and other mammals